TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32719254

Group type: EXPERIMENTAL
Intervention: Concomitant boost radiotherapy (CBRT) - 45 Gy/25#/5-weeks and 18 Gy/10# concomitant boost in the last 2-weeks, total dose 63 Gy.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Concomitant boost with concurrent chemoradiation (CBRT + CCT) - CBRT with cisplatin 75 mg/m2 on day 1, 17, and 34.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard fractionation chemoradiation with concomitant chemotherapy (CFRT + CCT) - 64 Gy/32#/6.2 weeks, concurrent with cisplatin 75 mg/m2 on day 1, 22, and 42.
Number of subjects: 90
Study: 35473743

Group type: EXPERIMENTAL
Intervention: Continuous energy restriction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (5:2D)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (5:2N)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34410341

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 512
Study: 32371433

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) 400 mg at Weeks 0/2/4, then 200 mg every 2 weeks up to 96 weeks
Number of subjects: 89
Study: 35815022

Group type: EXPERIMENTAL
Intervention: BEAM intervention (10-week program including weekly videos, activities based on Unified Protocol therapy modules, telehealth group sessions, and online support forum)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) control group
Number of subjects: 65
Study: 35083557

Group type: EXPERIMENTAL
Intervention: Meperidine 12.5 mg (1 mL) added to 0.5% 10 mg (2 mL) of hyperbaric bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil 5 μg (1 mL) added to 0.5% 10 mg (2 mL) of hyperbaric bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Meperidine group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 34911073

Group type: EXPERIMENTAL
Intervention: Buffalo Concussion Treadmill Test (BCTT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cycling test of exertion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both tests
Number of subjects: 20
Study: 32421401

Group type: EXPERIMENTAL
Intervention: Carbetocin (100 μg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Oxytocin (10 IU)
Number of subjects: 160
Study: 36163869

Group type: EXPERIMENTAL
Intervention: Zanubrutinib (160 mg twice daily)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Ibrutinib (420 mg once daily)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Number of subjects: 415

Group type: COMPARATOR
Intervention: Ibrutinib
Number of subjects: 415
Study: 34043412

Group type: EXPERIMENTAL
Intervention: Neoadjuvant capecitabine and oxaliplatin (CAPOX) followed by concurrent radiation and capecitabine (CAPRT)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Neoadjuvant capecitabine and oxaliplatin (CAPOX)
Number of subjects: 301
Study: 32991110

Group type: EXPERIMENTAL
Intervention: Oral citrulline supplementation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group without citrulline supplementation
Number of subjects: 16
Study: 36129535

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) (30–60 s)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Cut cord milking (C-UCM) (20–30 cm)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intact cord milking (I-UCM) (3–4 strippings)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 64
Study: 33231879

Group type: EXPERIMENTAL
Intervention: Inotuzumab ozogamicin (InO)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard intensive chemotherapy (SC)
Number of subjects: 49
Study: 36136826

Group type: EXPERIMENTAL
Intervention: Specific practice (training on one form of a task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Varied practice (training on various forms of a task)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Varied practice
Number of subjects: 0
Study: 34187081

Group type: EXPERIMENTAL
Intervention: E-cigarettes (EC)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Nicotine Replacement Treatment (NRT)
Number of subjects: 135
Study: 33217770

Group type: EXPERIMENTAL
Intervention: Air polishing followed by scaling (AS)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Scaling followed by air polishing (SA)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Scaling followed by rubber cup polishing (SR)
Number of subjects: 173
Study: 34872748

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34485877

Group type: EXPERIMENTAL
Intervention: Sodium selenite 100 mcg/day
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 36008062

Group type: EXPERIMENTAL
Intervention: Web-based psychoeducational intervention integrating dialectical behavioural therapy and empowerment approach
Number of subjects: 86

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 86
Study: 32896291

Group type: EXPERIMENTAL
Intervention: rAd26-S (one dose)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: rAd5-S (one dose)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: rAd26-S and rAd5-S (prime-boost vaccination)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Frozen formulation
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Lyophilised formulation
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 76
Study: 36007135

Group type: EXPERIMENTAL
Intervention: 2.5 mL sodium bicarbonate in 240 mL isotonic nasal irrigation twice daily for 14 days
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 2.5 mL povidone-iodine 10% in 240 mL isotonic nasal irrigation twice daily for 14 days
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Nasal irrigation (both groups)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Twice daily irrigation (regardless of additive)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nasal irrigation participants
Number of subjects: 79
Study: 34704970

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin administered every 8 hours for 6 doses
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo administered every 8 hours for 6 doses
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 32458980

Group type: EXPERIMENTAL
Intervention: DIM 100 mg × 1/day for 1 year
Number of subjects: 23

Group type: COMPARATOR
Intervention: DIM-untreated age- and menopausal-status-matched women
Number of subjects: 23
Study: 35026158

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (60,000 IU per month)
Number of subjects: 21315

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21315
Study: 33840570

Group type: EXPERIMENTAL
Intervention: Piezoelectric tools
Number of subjects: 34

Group type: COMPARATOR
Intervention: Traditional oscillating saw
Number of subjects: 34
Study: 33287868

Group type: EXPERIMENTAL
Intervention: Acupuncture (Jin’s three-needle acupuncture) as adjunctive therapy with methadone maintenance therapy (MMT) for 30 min per session, 18 sessions over 6 weeks (3 per week).
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine care (MMT only).
Number of subjects: 140
Study: 36155742

Group type: EXPERIMENTAL
Intervention: SMS text messages to parents (twice daily for 1 year)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: SMS text messages to parents
Number of subjects: 268
Study: 33790343

Group type: EXPERIMENTAL
Intervention: Upper extremity treatment with sonification techniques
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard upper extremity motor rehabilitation (Control)
Number of subjects: 65
Study: 32788051

Group type: EXPERIMENTAL
Intervention: Dalfampridine (4-AP, 10 mg BID)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 35462324

Group type: EXPERIMENTAL
Intervention: Visual Thinking Strategies (VTS) integrated into three skills lab sessions via on-site sessions or real-time online videoconferencing sessions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Visual Thinking Strategies (VTS)
Number of subjects: 60
Study: 33407796

Group type: EXPERIMENTAL
Intervention: APOSEC (cell-free secretome of peripheral blood mononuclear cells) applied topically three times weekly for 4 weeks.
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo applied topically three times weekly for 4 weeks.
Number of subjects: 132
Study: 35397090

Group type: EXPERIMENTAL
Intervention: Heated humidified high‐flow nasal cannula (HHHFNC)
Number of subjects: 124

Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 124
Study: 33861881

Group type: EXPERIMENTAL
Intervention: Image-and-text HWL (n = 135)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Text-only HWL (n = 129)
Number of subjects: 399

Group type: COMPARATOR
Intervention: No HWL (n = 135)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Image-and-text HWL
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Text-only HWL
Number of subjects: 399
Study: 34187130

Group type: EXPERIMENTAL
Intervention: Tualang honey nasal dressing (2 mL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Steroid nasal dressing (triamcinolone 20 mg/mL, 2 mL)
Number of subjects: 32
Study: 32200659

Group type: EXPERIMENTAL
Intervention: QL0902 (50 mg subcutaneous injection)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Reference Etanercept (50 mg subcutaneous injection)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Comparison of QL0902 and Reference Etanercept
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: QL0902
Number of subjects: 68
Study: 32589354

Group type: EXPERIMENTAL
Intervention: Self-tests offered to sexual partners
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: Self-tests offered during transactional sex encounters
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: Reactive HIV test results
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: Not offered a self-test
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: Refused to self-test
Number of subjects: 921
Study: 35081275

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34280297

Group type: EXPERIMENTAL
Intervention: Tailored yoga program (intervention group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 32088398

Group type: EXPERIMENTAL
Intervention: Chair Yoga (CY)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 112
Study: 35129525

Group type: COMPARATOR
Intervention: C‐Alc
Number of subjects: 3213

Group type: EXPERIMENTAL
Intervention: PI‐Alc
Number of subjects: 3213
Study: 33412596

Group type: EXPERIMENTAL
Intervention: Heparin (low-molecular-weight heparin or unfractionated heparin)
Number of subjects: 2574

Group type: COMPARATOR
Intervention: No heparin
Number of subjects: 2574

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 2574
Study: 32554025

Group type: EXPERIMENTAL
Intervention: swCRTdesign R package
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GUI for swCRTdesign
Number of subjects: 0
Study: 43637190

Group type: COMPARATOR
Intervention: 2 g oral dose of amoxicillin (Amoxil®)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2 g oral dose of amoxicillin with 100 mg of sodium diclofenac (Voltaren®)
Number of subjects: 20
Study: 35319989

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined high-dose radiotherapy and adoptive NK cell transfer
Number of subjects: 0
Study: 33270354

Group type: EXPERIMENTAL
Intervention: BMI increase before age 6 years
Number of subjects: 6130

Group type: EXPERIMENTAL
Intervention: BMI increase between ages 11 and 12
Number of subjects: 6130

Group type: EXPERIMENTAL
Intervention: Life course BMI associations with asthma and pulmonary function impairment at age 12 and asthma at age 17
Number of subjects: 6130
Study: 35466576

Group type: EXPERIMENTAL
Intervention: Social Inclusion context (SI)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Social Exclusion context (SE)
Number of subjects: 92
Study: 32092518

Group type: EXPERIMENTAL
Intervention: HgCl2 exposure at 25°C for 42 days
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: HgCl2 exposure at 28°C for 42 days
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: HgCl2 exposure at 31°C for 42 days
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: HgCl2 exposure at 34°C for 42 days
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group at 25°C for 42 days
Number of subjects: 5
Study: 33671082

Group type: EXPERIMENTAL
Intervention: Maximal-intensity aerobic exercise
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (48 h protocol)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ME/CFS (48 h protocol)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ME/CFS (72 h protocol)
Number of subjects: 22
Study: 35183991

Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy (TRT) of 60 Gy/40 fractions
Number of subjects: 150

Group type: COMPARATOR
Intervention: Thoracic radiotherapy (TRT) of 45 Gy/30 fractions
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both treatment arms (60 Gy and 45 Gy)
Number of subjects: 150
Study: 33677353

Group type: EXPERIMENTAL
Intervention: SKIN intervention (two-session intervention with psychoeducation, behavioral skills demonstrations, and motivational interviewing)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: SKIN intervention
Number of subjects: 252

Group type: COMPARATOR
Intervention: Assessment-only (AO) condition
Number of subjects: 252
Study: 36054754

Group type: EXPERIMENTAL
Intervention: Spaced Instruction (SI)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Mass Instruction (MI)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Supervised practice sessions
Number of subjects: 148
Study: 34996514

Group type: EXPERIMENTAL
Intervention: Reading a book in bed before going to sleep
Number of subjects: 991
Study: 33349049

Group type: EXPERIMENTAL
Intervention: 4 screws (4S)
Number of subjects: 2

Group type: COMPARATOR
Intervention: 6 screws (6S)
Number of subjects: 2
Study: 33001711

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: All conditions (Anodal, Cathodal, Sham)
Number of subjects: 39
Study: 34162016

Group type: EXPERIMENTAL
Intervention: Dinoprostone vaginal insert (DVI) alone
Number of subjects: 208

Group type: COMPARATOR
Intervention: Dinoprostone vaginal insert (DVI) with adjunctive sweeping of membranes (ASM)
Number of subjects: 208
Study: 32980658

Group type: EXPERIMENTAL
Intervention: Videos with shocking content (Australian school)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videos with punitive content (American school)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videos with technical content (European school)
Number of subjects: 0
Study: 34715833

Group type: EXPERIMENTAL
Intervention: mLab App intervention including HIV home test kits and standard of preventive care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of preventive care only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIV home test kits and standard of preventive care only
Number of subjects: 0
Study: 32531482

Group type: EXPERIMENTAL
Intervention: Asthma-tailored pulmonary rehabilitation (AT-PR)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 61
Study: 34047872

Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + AgNP
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 2% CHX gel + AgNP
Number of subjects: 5

Group type: COMPARATOR
Intervention: Ca(OH)2
Number of subjects: 5

Group type: COMPARATOR
Intervention: 2% CHX gel
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline solution (SS)
Number of subjects: 5
Study: 32589073

Group type: EXPERIMENTAL
Intervention: CELBESTA®
Number of subjects: 119

Group type: COMPARATOR
Intervention: CELEBREX®
Number of subjects: 119
Study: 34275430

Group type: EXPERIMENTAL
Intervention: Art intervention (n=11)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (n=11)
Number of subjects: 22
Study: 33563619

Group type: EXPERIMENTAL
Intervention: Deimplementation strategy consisting of education, audit and feedback
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group (before intervention)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Deimplementation strategy
Number of subjects: 5
Study: 36428014

Group type: EXPERIMENTAL
Intervention: MEDIC treatment (patient education, supervised exercise, weight loss, insoles, pain medication)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Written advice (two leaflets)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: KR (Knee Replacement)
Number of subjects: 100
Study: 33938874

Group type: EXPERIMENTAL
Intervention: XiaojiDaozhi Decoction
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 32819305

Group type: EXPERIMENTAL
Intervention: BCD-022
Number of subjects: 225

Group type: COMPARATOR
Intervention: Reference trastuzumab
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: BCD-022 and Reference trastuzumab
Number of subjects: 225
Study: 34091726

Group type: EXPERIMENTAL
Intervention: Surgical mask (SM)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: FFP2 mask (FFP2)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No mask (NM)
Number of subjects: 16
Study: 34529340

Group type: EXPERIMENTAL
Intervention: Triple bristles three‐sided sonic powered toothbrush
Number of subjects: 52

Group type: COMPARATOR
Intervention: Manual toothbrush with flat trimmed bristles
Number of subjects: 52
Study: 34519161

Group type: EXPERIMENTAL
Intervention: E‐WAA treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham control group
Number of subjects: 50
Study: 33794865

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg) once a day for 3 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo once a day for 3 months
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg) and Placebo
Number of subjects: 90
Study: 35144591

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 449
Study: 34836391

Group type: EXPERIMENTAL
Intervention: SWAP IT m-health intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 12
Study: 34632493

Group type: EXPERIMENTAL
Intervention: 25-gauge BD Vacutainer UltraTouch Push Button Blood Collection Set
Number of subjects: 101

Group type: COMPARATOR
Intervention: 23-gauge BD Vacutainer Standard Push Button Blood Collection Set
Number of subjects: 101
Study: 33757321

Group type: EXPERIMENTAL
Intervention: Pharmacist-led VTE risk assessment program using the Khorana Risk Score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Khorana Risk Score
Number of subjects: 0
Study: 33238936

Group type: EXPERIMENTAL
Intervention: Conventional confectionery ad
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: Pseudo-healthy confectionery ad
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: Conventional confectionery ad + counter-ad
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: Pseudo-healthy confectionery ad + counter-ad
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: Counter-ad
Number of subjects: 1613

Group type: COMPARATOR
Intervention: Non-food ad (control)
Number of subjects: 1613
Study: 34297221

Group type: EXPERIMENTAL
Intervention: Behavioural intervention (ACTIVE intervention using a fatigue propensity tool)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Information alone (control group)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Behavioural intervention (ACTIVE intervention)
Number of subjects: 75
Study: 34243077

Group type: EXPERIMENTAL
Intervention: Transarterial radioembolisation (TARE)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 285
Study: 36280851

Group type: EXPERIMENTAL
Intervention: Enalapril-folic acid
Number of subjects: 20702
Study: 33609021

Group type: EXPERIMENTAL
Intervention: Propolis extract gel (2% propolis, 0.2% ascorbic acid, 0.2% tocopherol acetate) applied 3 times/day for a week
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo gel applied 3 times/day for a week
Number of subjects: 15
Study: 33028387

Group type: EXPERIMENTAL
Intervention: Mothers Moving towards Empowerment (MME) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MME intervention
Number of subjects: 0
Study: 34992091

Group type: EXPERIMENTAL
Intervention: DCVAC/OvCa parallel to chemotherapy (Group A)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: DCVAC/OvCa sequential to chemotherapy (Group B)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Chemotherapy alone (Group C)
Number of subjects: 99
Study: 33074442

Group type: EXPERIMENTAL
Intervention: Dendritic cell therapy with HSP70 mRNA transfection
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 32496624

Group type: EXPERIMENTAL
Intervention: Triangular neck implants
Number of subjects: 34

Group type: COMPARATOR
Intervention: Circular neck implants
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 34134822

Group type: EXPERIMENTAL
Intervention: Exposure Guide (EG) training and feedback
Number of subjects: 8

Group type: COMPARATOR
Intervention: Baseline phase (gold-standard exposure therapy training with weekly consultation)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: EG training
Number of subjects: 8
Study: 34531274

Group type: EXPERIMENTAL
Intervention: BAY 2253651 (nasally applied genioglossus muscle activator via pharyngeal mucosal receptor stimulation)
Number of subjects: 0
Study: 32678677

Group type: EXPERIMENTAL
Intervention: Curcumagalactomannosides (CGM) (400 mg) with glucosamine hydrochloride (GLN) (500 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Chondroitin sulfate (CHN) (415 mg) with glucosamine hydrochloride (GLN) (500 mg)
Number of subjects: 80
Study: 35394599

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 1298

Group type: COMPARATOR
Intervention: Mentoring relationship quality
Number of subjects: 1298